In pancreatic cancer, the DNA methylation level of IGF2BP3 is significantly reduced, and the expression level of IGF2BP3 is increased, which is related to the poor overall survival of patients. The gene discussed is IGF2BP3; the disease is familial pancreatic carcinoma.